FDA Brief

Warning letters Food

FDA warning letter to

Conservas Ortiz S.A.

High riskIssued Jun 17, 2022Posted Jun 28, 2022Center for Food Safety and Applied Nutrition (CFSAN)

FDA warns Conservas Ortiz S.A. that its canned tuna HACCP plan lacks controls for histamine and Staphylococcus aureus toxin.

What happened

FDA inspected the canned tuna facility in Ondarroa, Spain, from February 14 through 16, 2022, and issued a Form FDA-483 listing inspection observations. FDA found the firm’s HACCP (a required food-safety plan) for canned tuna did not include required critical control points and critical limits for histamine (scombrotoxin) and Staphylococcus aureus toxin, had inadequate label monitoring, and had corrective actions that did not ensure unsafe product stayed out of commerce. The company responded March 8 and April 11, 2022, with an updated plan and records, but FDA still found significant deviations.

What FDA found

  1. The canned tuna HACCP plan lacks required control points for histamine formation after a processing step and for Staphylococcus aureus growth and toxin formation from post-cooking steps until the retort heats the product.

    21 CFR 123.6(c)(2)
  2. The HACCP plan lacks a critical limit for internal fish temperature when fish are offloaded from the harvest vessel at receiving, to control histamine formation.

    21 CFR 123.6(c)(3)
  3. The plan’s sensory limit for decomposed fish is not adequate to control histamine formation; FDA recommends less than 2.5% decomposition in the sample.

    21 CFR 123.6(c)(3)
  4. The plan’s critical limits for refrigerated storage/processing and unrefrigerated processing are combined in a way that does not adequately control histamine formation.

    21 CFR 123.6(c)(3)
  5. The label-monitoring frequency at the labeling control point is not specific enough to control undeclared allergens, because the “middle” of labeling is not defined.

    21 CFR 123.6(c)(4)
  6. The corrective actions for histamine and sensory failures do not ensure unsafe product is rejected or diverted from food use, so unsafe product could reach consumers.

    21 CFR 123.7(b)

What FDA wants

FDA asks the company to respond in writing within 15 working days with the specific corrections, a revised HACCP plan, and five consecutive days of completed monitoring records for five production date codes; if corrections cannot be completed in 15 days, explain the delay and when they will be finished.

Who should pay attention

  • U.S. importers of canned tuna from Spain
  • retailers and foodservice buyers sourcing canned tuna
  • seafood processors with similar HACCP plans

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Ocean Pride Seafood, Inc.

    FDA warned Ocean Pride Seafood that its ready-to-eat seafood was adulterated (unsafe under law) due to missing seafood safety (HACCP) controls and insanitary conditions.

    High risk
  2. Star Ocean Wholesale Foods, Inc.

    FDA warns Star Ocean Wholesale Foods over missing checks for imported fermented fish sauce.

    High risk
  3. South Asian Food Inc.

    South Asian Food Inc. lacked seafood HACCP import verification and pest controls for imported dried seafood.

    High risk
  4. AF Import & Wholesale Co

    FDA warned Houston seafood importer AF Import & Wholesale for missing written verification that its imported fish was processed safely.

    High risk